Health AI Central

Company profile

IMBIO

Medical Imaging & Radiology
Visit website

Company profile

About IMBIO

Imbio is a medical imaging artificial intelligence company specializing in chronic lung and cardiothoracic disease analysis. The company develops advanced algorithms that extract quantitative data from standard CT scans and X-rays to enable earlier detection, more accurate diagnosis, and personalized treatment planning. Imbio's product portfolio includes Lung Density Analysis (both inspiratory and functional), Lung Texture Analysis, Pulmonary Hypertension Assessment, Airway Analysis, and Coronary Artery Calcification tools. The company's technology utilizes parametric response mapping and other advanced image analysis techniques to provide functional pictures of the lung, making it particularly useful for assessing conditions like chronic bronchitis, COPD, and interstitial lung diseases. Imbio serves physicians, radiologists, and healthcare systems globally through various deployment options including companion imaging integration. In December 2023, Imbio entered a binding agreement to be acquired by 4DMedical, an Australian respiratory imaging technology company, creating a comprehensive cardiothoracic image analysis portfolio. The combined entity aims to transform patient care by turning standard medical imaging into personalized medicine for discovering, diagnosing, treating, and managing respiratory conditions.

Company description IMBIO official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at IMBIO?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Airborne Toxin Exposure
  • Burn Pit Exposure Effects
  • Chronic Bronchitis
  • COPD
  • Coronary Artery Disease
  • Interstitial Lung Disease
  • IPF
  • Pulmonary Hypertension

Who it serves

  • Healthcare Systems
  • Pulmonologists
  • Radiologists
  • Research Institutions
  • VA Hospitals

Deployment & integration

Cloud Saas · On Premise deployment with recorded integration context.

Recorded integration context: Aidoc, Blackford Analysis, MEDICAL-NOTE, Nuance AI Marketplace, Riverain Technologies.

Geographic context

MarketsAustralia · Italy · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

Acquired by 4DMedical in December 2023. Distribution agreement with Blackford signed February 2024. TGA approval for CT:VQ received June 2024. Partnership with MEDICAL-NOTE for Italian market expansion 2021.

Partnerships

Recorded partners

  • 4DMedical (acquirer)
  • Aidoc
  • Blackford Analysis
  • Heart&Lung Health Ltd
  • Inari Medical
  • MEDICAL-NOTE
  • Olympus Corporation
  • Riverain Technologies
  • University of Michigan

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

4DMedical CT LVAS™

4DMedical CT lung ventilation analysis solution

Software · Cloud SaaSCompany source

4DMedical XV LVAS®

4DMedical X-ray ventilation lung analysis solution

Software · Cloud SaaSCompany source

Airway Analysis

Quantitative airway analysis for respiratory disease assessment

Software · Cloud SaaSCompany source

Coronary Artery Calcification (CAC™)

Automated coronary artery calcium scoring for cardiac risk assessment

Software · Cloud SaaSCompany source

Coronary Calcification

Automated coronary calcium scoring from chest CT

Software · Cloud SaaSCompany source

CT LVAS™

CT-based Lung Ventilation Analysis for respiratory assessment

Software · Cloud SaaSCompany source

CT:VQ™

Non-Contrast Ventilation-Perfusion imaging for functional lung assessment

Software · Cloud SaaSCompany source

IQ-UIP™

Early detection of Idiopathic Pulmonary Fibrosis (IPF)

Software · Cloud SaaSCompany source

Lung Density Analysis™ - Functional (LDAf)

Patented Parametric Response Mapping (PRM) technology for complete COPD mapping

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

ALKBH10B mediated epitranscriptomic regulation enhances drought tolerance of Arabidopsis thaliana via hormonal cross-talk and sustained photosynthesis.

Plant cell reports · Aug 21, 2026

Phospholipid homeostasis and gametophyte development require the glycerophosphodiester phosphodiesterases GDPD5 and GDPD6.

Plant physiology · Aug 7, 2026

Heterodera schachtii enolase does not elicit canonical immune responses in Arabidopsis thaliana.

Scientific reports · Jun 8, 2026

Adaptation of lipid metabolism of the polyextremophilic cyanobacterium Cyanobacterium aponinum PCC 10605 to adverse environmental conditions.

BMC plant biology · Apr 22, 2026

Regulation of Tocopherol (Vitamin E) biosynthesis in Arabidopsis.

Journal of experimental botany · Apr 16, 2026

Future perspectives in mass spectrometry of plant lipids.

Planta · Mar 24, 2026

Clinical validation

Clinical-trial records

Personalized Smoking Cessation Tool Based on Patient Lung CT Image

NCT03087617 · Sponsor · COMPLETED

Regulatory

Regulatory records

IQ-UIP

K242467 · 510k · Dec 19, 2024

Imbio PHA (4.0.0)

K241847 · 510k · Aug 30, 2024

CAC Software

K230112 · 510k · Jun 13, 2023

Imbio RV/LV Software

K203256 · 510k · Mar 9, 2021

Lung Density Analysis

K141069 · 510k · Sep 17, 2014

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Early detection of air-trapping patterns

In veterans with normal pulmonary function tests

Functional lung assessment

From standard imaging without contrast agents

University of Michigan Veterans Study

Identification of air-trapping patterns characteristic of chronic bronchitis/deployment-related respiratory disease in veterans with normal pulmonary function tests

Successfully identified constrictive bronchiolitis patterns in veterans using parametric response mapping, revealing severity worse than mild to moderate COPD

Read source

Veterans Affairs (VA) Hospitals

Diagnosis and treatment of veterans exposed to toxic substances and airborne hazards (burn pits) during service, enabled by PACT Act passage

Enabling millions of veterans to get treatment for undiagnosed breathing conditions through non-invasive diagnosis using XV Technology on standard X-ray scans

Read source

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from IMBIO

Recent articles published on IMBIO's official website.

Imbio Partners with MEDICAL-NOTE to Expand Image Analysis Tool Offering to Clinicians across Italy

Read on IMBIO

Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio

Read on IMBIO

4DMedical Signs Distribution Agreement with Blackford

Read on IMBIO

Olympus Makes SeleCT™ QCT Analysis Available Nationwide via the Nuance AI Marketplace to Increase Access to Spiration Valve System Therapy

Read on IMBIO

Imbio Partners with Heart&Lung Health Ltd to Serve the UK Market with Enhanced Quantitative Imaging Services

Read on IMBIO

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

WebsiteOfficial websiteOpen link WebsiteOfficial websiteOpen link BlogCompany updatesOpen link SolutionsCompany product sourceOpen link CareersCompany hiringOpen link LinkedInCompany profileOpen link X / TwitterCompany updatesOpen link

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market
A2z Radiology AiView profile Adas3D Medical S.LView profile AEYE HealthView profile Agfa HealthCare N.V.View profile AI4MedImaging Medical SolutionsView profile AidenceView profile AidocView profile Aikenist Technologies Pvt LtdView profile AIQ GlobalView profile ALGOMEDICAView profile

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon